← Back to Search

N/A

Low omega-6/high omega-3 diet for Asthma

N/A
Waitlist Available
Led By Tanya M Laidlaw, MD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this trial is to test the hypothesis that a treatment diet low in omega-6 fatty acids and high in omega-3 fatty acids can cause improvement in asthma symptoms, nasal symptoms, and pulmonary function in patients with aspirin-exacerbated respiratory disease (AERD).

Eligible Conditions
  • Asthma
  • Respiratory Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Low omega-6/high omega-3 dietExperimental Treatment1 Intervention
Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams
Group II: Normal dietActive Control1 Intervention
Two weeks of unaltered diet
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams
2014
N/A
~10

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,666 Previous Clinical Trials
11,840,225 Total Patients Enrolled
44 Trials studying Asthma
220,176 Patients Enrolled for Asthma
Tanya M Laidlaw, MDPrincipal InvestigatorBrigham and Women's Hospital
2 Previous Clinical Trials
73 Total Patients Enrolled
1 Trials studying Asthma
33 Patients Enrolled for Asthma
~1 spots leftby Nov 2025